Similar companies
Related EMIS Industry Reports
Jiangsu Kanion Pharmaceutical Co., Ltd. was reorganized as a joint stock limited company in 2000 on the basis of Lianyungang Kanion Pharmaceutical Ltd. The company’s A shares were listed on Shanghai Stock Exchange on Sep. 18, 2002. The company is principally engaged in the research, development, manufacture and distribution of pharmaceuticals. It provides capsules, oral liquid, granules, tablets, pills and injections, including Anti-hyperosteogeny Capsule, Compound Danshen Granule, Jinzhen Oral Liquid, Clindamycin Phosphate Injection, Clindamycin Phosphate Injection, Pediatric Paracetamol, Artificial Cow-bezoar and Chlorphenamine Maleate Granules and Liuwei Dihuang Soft Capsule, among others. The company distributes its products primarily in domestic market.
Headquarters
Jiangning Industrial City, Economic and Technological Development Zone, Lianyungang City, Jiangsu Province
Lianyungang; Jiangsu;
Postal Code: 222047
Contact Details: Purchase the Jiangsu Kanion Pharmaceutical Co.,Ltd. report to view the information.
Website: http://www.kanion.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS service
To view more information, Request a demonstration of the EMIS service